Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose statin plus niacin vs low-dose statin in carotid atherosclerosis
2008-008006-46Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2009
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ulinastatin and niacin in carotid atheroma (CAS) and atherosclerosis (2 arms), sponsored by Merck & Co. Primary endpoints: Composite Hot/Cold RNA biomarker panel, Plaque Instability Protein composite and 1 more. Started Feb 2009; status: completed.
02
Drugs
ulinastatinniacin
03
Conditions
carotid atheroma (CAS)atherosclerosis
Beyond the preview
Go deeper on 2008-008006-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008006-46.